Antioxidants (Basel, Switzerland)

Frontiers in immunology

oxidative medicine and cellular longevity

journal of thoracic disease

annals of agricultural and environmental medicine : aaem

the journal of allergy and clinical immunology

american journal of physiology lung cellular and molecular physiology

[1] Across-shift changes in upper airways after exposure to bacterial cell wall components.

[2] Revisiting Airway Epithelial Remodeling in Type 2 Immunity: Beyond Goblet Cell Metaplasia.

[3] Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke.

[4] Inhibition of Galectin-3 Alleviates Cigarette Smoke Extract-Induced Autophagy and Dysfunction in Endothelial Progenitor Cells.

[5] PI3-Kinase δγ Catalytic Isoforms Regulate the Th-17 Response in Tuberculosis.

[6] Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease

[7] improvement of airflow limitation by fluticasone propionate/salmeterol in chronic obstructive pulmonary disease: what is the specific marker?

[8] effect of a leukotriene receptor antagonist pranlukast hydrate, on airway inflammation airway hyperresponsiveness in patients with moderate to severe asthma

[9] effects of asian dust particles on the early-stage antigen-induced immune response of asthma in nc/nga mice

[10] late airway obstruction and neutrophil infiltration in sensitized mice after antigen provocation were suppressed by selective and non-selective phosphodiesterase inhibitors

[11] analysis of the sputum and inflammatory alterations of the airways in patients with common variable immunodeficiency and bronchiectasis

[12] Critical roles of regulatory B and T cells in helminth parasite-induced protection against allergic airway inflammation.

[13] 14BME20 Prevents Allergic Airway Inflammation by Induction of Regulatory T Cells via Interleukin-10.

[14] Epigallocatechin gallate ameliorates airway inflammation by regulating Treg/Th17 imbalance in an asthmatic mouse model.

[15] Indoor PM from coal combustion aggravates ovalbumin-induced asthma-like airway inflammation in BALB/c mice.

[16] Interleukin-2/antibody complex expanding Foxp3 regulatory T cells exacerbates Th2-mediated allergic airway inflammation.

[17] Schistosoma mansoni-mediated suppression of allergic airway inflammation requires patency and Foxp3+ Treg cells.

[18] IL-21 promotes allergic airway inflammation by driving apoptosis of FoxP3 regulatory T cells.

[19] Luteolin attenuates airway inflammation by inducing the transition of CD4CD25 to CD4CD25 regulatory T cells.

[20] Modified Si-Jun-Zi-Tang attenuates airway inflammation in a murine model of chronic asthma by inhibiting Teff cells via the mTORC1 pathway

[21] Effects of VAChT reduction and α7nAChR stimulation by PNU-282987 in lung inflammation in a model of chronic allergic airway inflammation.

[22] illicium verum extract and trans-anethole attenuate ovalbumin-induced airway inflammation via enhancement of foxp3+ regulatory t cells and inhibition of th2 cytokines in mice

[23] a purinergic p2y6 receptor agonist prodrug modulates airway inflammation, remodeling, and hyperreactivity in a mouse model of asthma

[24] effect of procaterol, a β2 selective adrenergic receptor agonist, on airway inflammation and hyperresponsiveness

[25] leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded rna-induced asthma exacerbation model

[26] effect of a leukotriene receptor antagonist pranlukast hydrate, on airway inflammation airway hyperresponsiveness in patients with moderate to severe asthma

[27] critical role of cd44 in antigen-induced th2- but not th17-madiated murine airway inflammation

[28] isu201 enhances the resolution of airway inflammation in a mouse model of an acute exacerbation of asthma

[29] ccr9 is a key regulator of early phases of allergic airway inflammation

[30] Effect of sildenafil on acrolein-induced airway inflammation and mucus production in rats